|
End-of-day quote
Shenzhen S.E.
2026-09-30
|
5-day change | 1st Jan Change | ||
| 47.25 CNY | -1.03% |
|
-5.50% | +61.26% |
| Market Cap | 5.12B 764M 678M 634M 578M 1.08B 73.56B 1.1B 7.66B 2.97B 37.47B 2.87B 2.81B 121B | P/E 2024 |
53.4x | P/E 2025 | 195x |
|---|---|---|---|---|---|
| Enterprise Value | 4.87B 727M 645M 603M 550M 1.03B 70.02B 1.05B 7.29B 2.82B 35.66B 2.73B 2.67B 115B | EV / Sales 2024 |
6.15x | EV / Sales 2025 | 7.35x |
| Free-Float |
41.05% | Yield 2024 |
0.67% | Yield 2025 | 0.17% |
| 1 day | -1.03% | ||
| 1 week | -5.50% | ||
| 1 month | +0.96% | ||
| 3 months | -4.16% | ||
| 6 months | +33.02% | ||
| Current year | +61.26% |
| 1 week | 46.08 | 49.59 | |
| 1 month | 44.78 | 53.19 | |
| Current year | 28.3 | 59.24 | |
| 1 year | 25.87 | 59.24 | |
| 3 years | 18.52 | 59.24 | |
| 5 years | 18.52 | 63.99 | |
| 10 years | 18.52 | 63.99 |
| Manager | Title | Age | Since |
|---|---|---|---|
Zhi Guo Wei
PSD | President | 47 | 2026-03-11 |
Yan Bing Li
DFI | Director of Finance/CFO | 44 | 2026-03-11 |
Gong Yuan Chang
IRC | Investor Relations Contact | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Xiao Hong Zou
BRD | Director/Board Member | 67 | 2015-09-05 |
Bin Wu
BRD | Director/Board Member | 66 | 2023-11-09 |
Hong Fu Li
CHM | Chairman | 41 | 2025-11-30 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -1.03% | -5.50% | +37.47% | +16.41% | 763M | ||
| -0.62% | -0.10% | +50.70% | +114.07% | 1,031B | ||
| -2.30% | -3.90% | +39.50% | +66.07% | 638B | ||
| -0.63% | -1.94% | +12.26% | +74.38% | 462B | ||
| -1.03% | -2.88% | +71.35% | +39.69% | 359B | ||
| -0.03% | -3.91% | +34.28% | +39.35% | 335B | ||
| -1.58% | +0.39% | +17.92% | +25.77% | 273B | ||
| -2.02% | -3.20% | +7.60% | +8.38% | 253B | ||
| -3.38% | +0.29% | +44.32% | +51.54% | 228B | ||
| -1.04% | -2.56% | +32.88% | +96.82% | 185B | ||
| Average | -0.69% | -0.88% | +34.83% | +53.25% | 376.46B | |
| Weighted average by Cap. | -0.24% | -0.35% | +38.05% | +69.17% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 464M 69.23M 61.44M 57.42M 52.35M 98.26M 6.67B 99.92M 694M 269M 3.4B 260M 254M 10.94B | 398M 59.45M 52.77M 49.31M 44.96M 84.38M 5.73B 85.81M 596M 231M 2.92B 223M 218M 9.39B |
| Net income | 60.27M 9M 7.99M 7.46M 6.8M 12.77M 867M 12.99M 90.21M 34.94M 441M 33.78M 33.05M 1.42B | 16.55M 2.47M 2.19M 2.05M 1.87M 3.51M 238M 3.57M 24.78M 9.6M 121M 9.28M 9.08M 391M |
| Net Debt | -387M -57.76M -51.27M -47.9M -43.68M -81.98M -5.56B -83.37M -579M -224M -2.83B -217M -212M -9.13B | -247M -36.83M -32.69M -30.55M -27.86M -52.28M -3.55B -53.16M -369M -143M -1.81B -138M -135M -5.82B |
Employees
650
Sector
Pharmaceuticals
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-09-30 | CN¥47.25 | -1.03% | 1,590,083 |
| 26-09-29 | CN¥47.74 | +1.79% | 1,427,645 |
| 26-09-28 | CN¥46.90 | -4.91% | 2,417,283 |
| 26-09-24 | CN¥49.32 | -1.36% | 2,576,582 |
| 26-09-23 | CN¥50.00 | -1.44% | 1,854,675 |
- Stock Market
- Stocks
- 301281 Stock
Select your edition
All financial news and data tailored to specific country editions
















